Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Nova Mentis Expands Pre-Clinical Development Pipeline; Company Begins Fragile X Syndrome Treatment with its Proprietary Psilocybin Drug

Nova Mentis Expands Pre-Clinical Development Pipeline; Company Begins Fragile X Syndrome Treatment with its Proprietary Psilocybin Drug

  • Post published:February 18, 2021
  • Post category:Press Release
Read more about the article Nova Mentis Appoints Gary R. Harlem to Scientific Advisory Board

Nova Mentis Appoints Gary R. Harlem to Scientific Advisory Board

  • Post published:February 11, 2021
  • Post category:Press Release
Read more about the article Nova Mentis Psilocybin Approved for Shipment to Italy

Nova Mentis Psilocybin Approved for Shipment to Italy

  • Post published:February 9, 2021
  • Post category:Press Release
Read more about the article Nova Launches Preclinical Autism Spectrum Disorder Therapeutic Study

Nova Launches Preclinical Autism Spectrum Disorder Therapeutic Study

  • Post published:January 26, 2021
  • Post category:Press Release
Read more about the article Nova Mentis Appoints Dr. Julia V. Perederiy, PhD to Scientific Advisory Board

Nova Mentis Appoints Dr. Julia V. Perederiy, PhD to Scientific Advisory Board

  • Post published:January 13, 2021
  • Post category:Press Release
Read more about the article Nova Mentis Appoints Dr. Kyle Ambert to Scientific Advisory Board

Nova Mentis Appoints Dr. Kyle Ambert to Scientific Advisory Board

  • Post published:January 4, 2021
  • Post category:Press Release
Read more about the article Nova Mentis Expands Psychedelic Drug Pipeline

Nova Mentis Expands Psychedelic Drug Pipeline

  • Post published:December 29, 2020
  • Post category:Press Release
Read more about the article Nova Mentis Uncovers Diagnostic Biomarkers in Preclinical Autism Study

Nova Mentis Uncovers Diagnostic Biomarkers in Preclinical Autism Study

  • Post published:December 8, 2020
  • Post category:Press Release
Read more about the article Nova Mentis Appoints Dr. Marvin S. Hausman as Chairman of Scientific Advisory Board

Nova Mentis Appoints Dr. Marvin S. Hausman as Chairman of Scientific Advisory Board

  • Post published:December 3, 2020
  • Post category:Press Release
Read more about the article Nova Mentis Life Science Completes Acquisition of Pilz Bioscience

Nova Mentis Life Science Completes Acquisition of Pilz Bioscience

  • Post published:November 30, 2020
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More